PT  - JOURNAL ARTICLE
AU  - Yunir, Em
AU  - Wafa, Syahidatul
AU  - Tahapary, Dicky L.
AU  - Rusdi, Lusiani
AU  - Lestari, Yeni D.
AU  - Nugroho, Pringgodigdo
AU  - Nachrowi, Annisa P.
AU  - Khumaedi, Anandhara I.
AU  - Tarigan, Tri J.E.
AU  - Salim, Simon
AU  - Adriono, Gitalisa A.
AU  - Mansjoer, Arif
AU  - Waspadji, Sarwono
AU  - Subekti, Imam
AU  - Harbuwono, Dante S.
AU  - Soebardi, Suharko
AU  - Darmowidjojo, Budiman
AU  - Purnamasari, Dyah
AU  - Wisnu, Wismandari
AU  - Kurniawan, Farid
AU  - Rosana, Martha
AU  - Wildan, Ardy
AU  - Christabel, Eunike V.
AU  - Pradnjaparamita, Tika
AU  - Amalina, Nida
AU  - Wahyuningsih, Endang S.
AU  - Novita, SW
AU  - Damayanti, Fitri
AU  - Vanessa, Vinny
AU  - Alwi, Idrus
AU  - Dwi Oktavia, TLH
AU  - Sitompul, Ratna
AU  - Soewondo, Pradana
TI  - Integration of Hybrid Model Diabetes Self-Management Education and Support at Primary Health Care During COVID-19 Pandemic: Protocol Paper of DIAJAPRI Health Coaching Study
AID  - 10.1101/2022.12.18.22283494
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.12.18.22283494
4099  - http://medrxiv.org/content/early/2022/12/19/2022.12.18.22283494.short
4100  - http://medrxiv.org/content/early/2022/12/19/2022.12.18.22283494.full
AB  - Introduction COVID -19 pandemic has threatened the optimal achievement on type-2 diabetes mellitus (T2DM) target in primary health care (PHC), due to our priority in COVID-19 management, limited access of patients to PHC and their lifestyle changes as the impact of social restrictions. Therefore, the empowerment of capability of patients on diabetes self-care is required through optimal education and support. The use of telehealth in T2DM management has benefits on improving outcomes of patients. We aim to assess the role of telehealth diabetes self-management education (DSME) versus hybrid (telehealth and face-to-face method) diabetes self-management education and support (DSMES) to improve T2DM outcomes in PHC during COVID-19 pandemic.Methods and analysis This study is an open label randomized-controlled trial that will be conducted in 10 PHCs in Jakarta, Indonesia, involving patients with T2DM. Subjects are classified into 2 groups: DSME group and DSMES group. Intervention will be given every 2 weeks. DSME group will receive 1 educational video every 2 weeks discussing topics about diabetes self-management, while DSMES group will receive 1 educational video and undergo 1 coaching session every 2 weeks. All interventions will be conducted by trained health workers of PHC, who are physicians, nurses, and nutritionists. Our primary outcome is the change of HbA1C level and our secondary outcomes are the changes of nutritional intake, physical activity, quality of life, anthropometric parameter, fasting blood glucose, lipid profile, inflammatory markers, and progression of diabetes complications at 3 and 6 months after intervention compare to the baseline.Ethics and dissemination This study protocol has been approved by the Health Research Ethics Committee University of Indonesia. Subjects agree to participate will be given written informed consent prior to data collection. Findings from this study will be published in peer-reviewed journals and presented at conferences.Trial Registration http://www.clinicalstrials.gov with identifier number NCT05090488.Strengths and limitations of the studyThis study evaluates the role of hybrid DSMES, which is useful in areas with limited access or on lockdowns.This study will evaluates the implementation of hybrid DSMES, its benefits, difficulties, and obstacles.We uses validated questionnaire instruments and routinely collected clinical data.Because all of our interventions will be conducted by PHCs’ health workers, our results depend on the ability and adherence of PHCs’ health workers.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05090488Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Faculty of Medicine, University of Indonesia gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsT2DMtype-2 diabetes mellitusPHCprimary health careOADoral anti-diabeticDSMESdiabetes self-management education and supportSMBGself-monitoring of blood glucose